US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Contineum Therapeutics, INC.

17.19

+1.177.30%

Post-market: 17.190.00000.00%19:30 EDT

Volume:353.91K

Turnover:6.02M

Market Cap:646.71M

PE:-9.99

High:17.35

Open:16.18

Low:15.88

Close:16.02

52wk High:17.35

52wk Low:8.60

Shares:37.62M

Float Shares:27.82M

Volume Ratio:0.42

T/O Rate:1.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7201

EPS(LYR):-2.1700

ROE:-28.01%

ROA:-19.15%

PB:2.70

PE(LYR):-7.92

Loading ...

Overview Company News Filings

Contineum Stockholders Hold 2026 Virtual Annual Meeting

Contineum Therapeutics Shareholders Elect Class II Directors at Annual Meeting

Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19

Contineum Therapeutics to present at Goldman Sachs Global Healthcare Conference

Contineum Therapeutics grants 51,000-share inducement stock option to new employee

Contineum Therapeutics Is Maintained at Equal-Weight by Morgan Stanley

Contineum price target raised to $16 from $14 at Morgan Stanley

Morgan Stanley Raises Price Target on Contineum Therapeutics to $16 From $14, Keeps Equalweight Rating

MT Newswires Live

Contineum Therapeutics to present at RBC Capital Markets Global Healthcare Conference

Contineum presents PIPE-791 pulmonary fibrosis data at ATS 2026 conference

Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)

Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate

Benzinga Earnings

Contineum Q1 FY26 net loss narrows 9.6% to $14.5 million

Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares

Contineum Therapeutics grants 102,000 inducement stock options to new hires

Contineum Therapeutics announces annual shareholder meeting

Contineum reports positive Phase 1b data for PIPE-791 in chronic pain trial

Contineum Therapeutics Inc - Pipe-791 Phase 1B Trial Achieves Primary Endpoint for Safety and Tolerability

THOMSON REUTERS

Contineum Therapeutics Reports Positive Topline Data From Its Exploratory Pipe-791 Phase 1B Trial in Chronic Pain

THOMSON REUTERS

Contineum Therapeutics Inc - No Serious Adverse Events Reported in Pipe-791 Phase 1B Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CTNM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CTNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","market":"US","secType":"STK","nameCN":"Contineum Therapeutics, INC.","latestPrice":17.19,"timestamp":1787342400000,"preClose":16.02,"halted":0,"volume":353907,"hourTrading":{"tag":"盘后","latestPrice":17.19,"preClose":17.19,"latestTime":"19:30 EDT","volume":1311,"amount":22537.56,"timestamp":1787355007001,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07303370786516865,"floatShares":27823300,"shares":37621100,"eps":-1.720127,"marketStatus":"Market Closed","change":1.17,"latestTime":"08-21 16:00:00 EDT","open":16.18,"high":17.35,"low":15.8801,"amount":6016230.721476,"amplitude":0.091754,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.720127,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":16.02,"postHourTrading":{"tag":"盘后","latestPrice":17.19,"preClose":17.19,"latestTime":"19:30 EDT","volume":1311,"amount":22537.56,"timestamp":1787355007001,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4171029327075562,"impliedVol":1.4272,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CTNM\",,,,,undefined,":{"symbol":"CTNM","floatShares":27823300,"roa":"-19.15%","roe":"-28.01%","lyrEps":-2.169999,"volumeRatio":0.4171029327075562,"shares":37621100,"dividePrice":0,"high":17.35,"amplitude":0.091754,"preClose":16.02,"low":15.8801,"week52Low":8.6,"pbRate":"2.70","week52High":17.35,"institutionHeld":0,"latestPrice":17.19,"eps":-1.720127,"divideRate":0,"volume":353907,"delay":0,"ttmEps":-1.720127,"open":16.18,"prevYearClose":11.43,"prevWeekClose":14.19,"prevMonthClose":15.49,"prevQuarterClose":16.39,"fiveDayClose":14.19,"twentyDayClose":14.06,"sixtyDayClose":13.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CTNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"CTNM","fiscalQuarterEnding":"2026/06","expectedEps":-0.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2026-05-05","symbol":"CTNM","fiscalQuarterEnding":"2026/03","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2026-03-05","symbol":"CTNM","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-10-30","symbol":"CTNM","fiscalQuarterEnding":"2025/09","expectedEps":-0.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-08-05","symbol":"CTNM","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CTNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CTNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1785556800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CTNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CTNM","date":"2026-08-21","current":-9.993448,"percent":0.145581,"low":-16.425726,"twenty":-9.774333,"median":-6.022053,"eighty":-2.376833,"high":28.322904,"avg":-3.947389,"sd":10.016915,"marketCap":602690534},"quantilePoints":[{"date":"2024-04-05","current":16.281367,"twenty":16.281367,"median":16.281367,"eighty":16.281367,"marketCap":369912656},{"date":"2024-04-12","current":17.609251,"twenty":16.281367,"median":16.569509,"eighty":16.868158,"marketCap":400082176},{"date":"2024-04-19","current":17.122563,"twenty":16.281367,"median":16.868158,"eighty":17.144685,"marketCap":389024629},{"date":"2024-04-26","current":17.686678,"twenty":16.315104,"median":17.089379,"eighty":17.59819,"marketCap":401841332},{"date":"2024-05-03","current":16.48102,"twenty":16.48102,"median":17.122563,"eighty":17.59819,"marketCap":374448771},{"date":"2024-05-10","current":17.719862,"twenty":16.38147,"median":17.105971,"eighty":17.59819,"marketCap":402595255},{"date":"2024-05-17","current":16.547386,"twenty":16.392531,"median":17.100441,"eighty":17.487579,"marketCap":375956618},{"date":"2024-05-24","current":17.819411,"twenty":16.48102,"median":17.133624,"eighty":17.59819,"marketCap":404857026},{"date":"2024-05-31","current":20.173009,"twenty":16.534113,"median":17.172337,"eighty":17.68889,"marketCap":385849140},{"date":"2024-06-07","current":21.67926,"twenty":16.768608,"median":17.354846,"eighty":18.209439,"marketCap":414659209},{"date":"2024-06-14","current":22.311348,"twenty":16.85046,"median":17.388029,"eighty":20.619504,"marketCap":426749148},{"date":"2024-06-21","current":26.466988,"twenty":16.894704,"median":17.487579,"eighty":21.17897,"marketCap":506234071},{"date":"2024-06-28","current":25.216261,"twenty":16.921251,"median":17.542884,"eighty":21.517876,"marketCap":482311425},{"date":"2024-07-05","current":27.018383,"twenty":16.987617,"median":17.609251,"eighty":21.78147,"marketCap":516780614},{"date":"2024-07-12","current":28.242212,"twenty":17.042923,"median":17.692208,"eighty":22.916538,"marketCap":540188796},{"date":"2024-07-15","current":27.932893,"twenty":17.049559,"median":17.697739,"eighty":23.766494,"marketCap":534272442},{"date":"2024-08-02","current":26.224911,"twenty":17.056196,"median":17.697739,"eighty":24.100021,"marketCap":501603882},{"date":"2024-08-09","current":22.338245,"twenty":17.08938,"median":17.819411,"eighty":24.409341,"marketCap":427263614},{"date":"2024-08-16","current":-15.206885,"twenty":17.023013,"median":17.769636,"eighty":24.100021,"marketCap":478195700},{"date":"2024-08-23","current":-14.92058,"twenty":16.547386,"median":17.697739,"eighty":23.683112,"marketCap":469192554},{"date":"2024-08-30","current":-15.468649,"twenty":16.315104,"median":17.614781,"eighty":23.293101,"marketCap":486427149},{"date":"2024-09-06","current":-14.511573,"twenty":15.417858,"median":17.570537,"eighty":22.830467,"marketCap":456330916},{"date":"2024-09-13","current":-14.765157,"twenty":-14.025672,"median":17.410151,"eighty":22.682531,"marketCap":464305131},{"date":"2024-09-20","current":-16.425726,"twenty":-14.408503,"median":17.365907,"eighty":22.459283,"marketCap":516523382},{"date":"2024-09-27","current":-15.272326,"twenty":-14.745525,"median":17.19999,"eighty":22.405488,"marketCap":480253562},{"date":"2024-10-04","current":-14.421591,"twenty":-14.887859,"median":17.133624,"eighty":22.351694,"marketCap":453501355},{"date":"2024-10-11","current":-13.521775,"twenty":-14.788061,"median":17.100441,"eighty":22.316727,"marketCap":425205752},{"date":"2024-10-18","current":-13.480875,"twenty":-14.745525,"median":17.039604,"eighty":22.010098,"marketCap":423919588},{"date":"2024-10-25","current":-13.309092,"twenty":-14.662087,"median":16.868158,"eighty":21.934785,"marketCap":418517700},{"date":"2024-10-31","current":-14.004404,"twenty":-14.595828,"median":16.547386,"eighty":21.78147,"marketCap":440382485},{"date":"2024-11-08","current":-13.455721,"twenty":-14.532841,"median":16.387,"eighty":21.655052,"marketCap":477166769},{"date":"2024-11-15","current":-13.193473,"twenty":-14.477216,"median":16.281367,"eighty":21.566291,"marketCap":467866942},{"date":"2024-11-22","current":-10.423934,"twenty":-14.434679,"median":15.167037,"eighty":21.517876,"marketCap":369653551},{"date":"2024-11-29","current":-10.838275,"twenty":-14.411775,"median":-9.795154,"eighty":21.388769,"marketCap":384346893},{"date":"2024-12-06","current":-10.358512,"twenty":-14.347406,"median":-10.271282,"eighty":21.17897,"marketCap":367333550},{"date":"2024-12-13","current":-10.031401,"twenty":-14.270231,"median":-10.358512,"eighty":21.154762,"marketCap":355733543},{"date":"2024-12-20","current":-9.70429,"twenty":-14.217087,"median":-10.242206,"eighty":20.950342,"marketCap":344133536},{"date":"2024-12-27","current":-10.569317,"twenty":-14.14183,"median":-10.271282,"eighty":20.635643,"marketCap":374809110},{"date":"2025-01-03","current":-10.525702,"twenty":-14.135286,"median":-10.358512,"eighty":20.603366,"marketCap":373262442},{"date":"2025-01-10","current":-9.718828,"twenty":-14.073857,"median":-10.358512,"eighty":20.25908,"marketCap":344649092},{"date":"2025-01-17","current":-9.071876,"twenty":-14.047944,"median":-10.256744,"eighty":19.850241,"marketCap":321706856},{"date":"2025-01-24","current":-8.19958,"twenty":-14.045305,"median":-10.209494,"eighty":18.599466,"marketCap":290773505},{"date":"2025-01-31","current":-7.429052,"twenty":-14.035488,"median":-10.009594,"eighty":17.759682,"marketCap":263449044},{"date":"2025-02-07","current":-6.883867,"twenty":-14.024036,"median":-9.925999,"eighty":17.706588,"marketCap":244115699},{"date":"2025-02-14","current":-5.589962,"twenty":-14.010948,"median":-9.718828,"eighty":17.697739,"marketCap":198231228},{"date":"2025-02-21","current":-5.742614,"twenty":-13.988044,"median":-9.667944,"eighty":17.693315,"marketCap":203644564},{"date":"2025-02-28","current":-5.19016,"twenty":-13.940599,"median":-9.518928,"eighty":17.660132,"marketCap":184053442},{"date":"2025-03-07","current":-3.942751,"twenty":-13.847345,"median":-9.071876,"eighty":17.615888,"marketCap":166612775},{"date":"2025-03-14","current":-4.371311,"twenty":-13.716463,"median":-8.19958,"eighty":17.604827,"marketCap":184722859},{"date":"2025-03-21","current":-4.377433,"twenty":-13.63957,"median":-8.126889,"eighty":17.576068,"marketCap":184981575},{"date":"2025-03-28","current":-4.561102,"twenty":-13.619937,"median":-7.567165,"eighty":17.520762,"marketCap":192743040},{"date":"2025-04-04","current":-3.75296,"twenty":-13.617995,"median":-7.116479,"eighty":17.456608,"marketCap":158592595},{"date":"2025-04-11","current":-2.528503,"twenty":-13.600664,"median":-6.847522,"eighty":17.401302,"marketCap":106849497},{"date":"2025-04-17","current":-2.681561,"twenty":-13.574128,"median":-6.436815,"eighty":17.385817,"marketCap":113317384},{"date":"2025-04-25","current":-2.767272,"twenty":-13.55286,"median":-5.742614,"eighty":17.372544,"marketCap":116939401},{"date":"2025-05-02","current":-2.430547,"twenty":-13.541408,"median":-5.640845,"eighty":17.334936,"marketCap":102710049},{"date":"2025-05-09","current":-2.418302,"twenty":-13.513595,"median":-5.553616,"eighty":17.244235,"marketCap":102192618},{"date":"2025-05-16","current":-2.045592,"twenty":-13.477603,"median":-5.430041,"eighty":17.188929,"marketCap":101933903},{"date":"2025-05-23","current":-2.030017,"twenty":-13.462755,"median":-5.321004,"eighty":17.144685,"marketCap":101157756},{"date":"2025-05-30","current":-1.853493,"twenty":-13.455721,"median":-5.117468,"eighty":17.144685,"marketCap":92361429},{"date":"2025-06-06","current":-2.154621,"twenty":-13.448154,"median":-4.770625,"eighty":17.122563,"marketCap":107366928},{"date":"2025-06-13","current":-2.40383,"twenty":-13.399073,"median":-4.628447,"eighty":17.122563,"marketCap":119785271},{"date":"2025-06-20","current":-1.895028,"twenty":-13.379975,"median":-4.585591,"eighty":17.104865,"marketCap":94431153},{"date":"2025-06-27","current":-2.081935,"twenty":-13.328858,"median":-4.536848,"eighty":17.091592,"marketCap":103744911},{"date":"2025-07-03","current":-2.014441,"twenty":-13.312364,"median":-4.445597,"eighty":17.06947,"marketCap":100381610},{"date":"2025-07-11","current":-2.092319,"twenty":-13.309092,"median":-4.377433,"eighty":17.036286,"marketCap":104262342},{"date":"2025-07-18","current":-1.993674,"twenty":-13.304184,"median":-4.325394,"eighty":16.96992,"marketCap":99346748},{"date":"2025-07-25","current":-2.959359,"twenty":-13.281279,"median":-4.150909,"eighty":16.894704,"marketCap":147467829},{"date":"2025-08-01","current":-3.063196,"twenty":-13.22336,"median":-4.01928,"eighty":16.841612,"marketCap":152642139},{"date":"2025-08-08","current":-3.062072,"twenty":-13.164683,"median":-3.75296,"eighty":16.657997,"marketCap":174115524},{"date":"2025-08-15","current":-3.58032,"twenty":-12.764301,"median":-3.489183,"eighty":16.507566,"marketCap":203584157},{"date":"2025-08-22","current":-4.951297,"twenty":-12.507357,"median":-3.639499,"eighty":16.427927,"marketCap":281540625},{"date":"2025-08-29","current":-4.956228,"twenty":-11.906412,"median":-3.948873,"eighty":16.385894,"marketCap":281821044},{"date":"2025-09-05","current":-5.419796,"twenty":-11.370375,"median":-4.039068,"eighty":16.354924,"marketCap":308180426},{"date":"2025-09-12","current":-5.824184,"twenty":-11.101417,"median":-4.150909,"eighty":16.301609,"marketCap":331174779},{"date":"2025-09-19","current":-6.115147,"twenty":-10.938589,"median":-4.325394,"eighty":16.232919,"marketCap":347719498},{"date":"2025-09-26","current":-5.355685,"twenty":-10.838275,"median":-4.374303,"eighty":15.930178,"marketCap":304534979},{"date":"2025-10-03","current":-5.301438,"twenty":-10.774307,"median":-4.411924,"eighty":15.250644,"marketCap":301450371},{"date":"2025-10-10","current":-5.996789,"twenty":-10.666723,"median":-4.53049,"eighty":8.143309,"marketCap":340989443},{"date":"2025-10-17","current":-6.144737,"twenty":-10.617293,"median":-4.573346,"eighty":-1.787038,"marketCap":349402011},{"date":"2025-10-24","current":-5.483906,"twenty":-10.566409,"median":-4.58636,"eighty":-1.820784,"marketCap":311825872},{"date":"2025-10-31","current":-5.197875,"twenty":-10.55914,"median":-4.692731,"eighty":-1.833764,"marketCap":295561573},{"date":"2025-11-07","current":-5.410266,"twenty":-10.548963,"median":-4.832939,"eighty":-1.851935,"marketCap":321299446},{"date":"2025-11-14","current":-5.356212,"twenty":-10.534425,"median":-4.919242,"eighty":-1.870107,"marketCap":318089369},{"date":"2025-11-21","current":-6.004854,"twenty":-10.522794,"median":-4.956228,"eighty":-1.897105,"marketCap":356610284},{"date":"2025-11-28","current":-5.439749,"twenty":-10.511164,"median":-5.1056,"eighty":-1.907489,"marketCap":323050396},{"date":"2025-12-05","current":-5.395524,"twenty":-10.480633,"median":-5.127036,"eighty":-1.940717,"marketCap":320423970},{"date":"2025-12-12","current":-6.422541,"twenty":-10.474818,"median":-5.15474,"eighty":-1.961484,"marketCap":381415418},{"date":"2025-12-19","current":-5.596996,"twenty":-10.473364,"median":-5.194017,"eighty":-1.980175,"marketCap":332388800},{"date":"2025-12-26","current":-6.230896,"twenty":-10.467549,"median":-5.225482,"eighty":-1.988482,"marketCap":370034239},{"date":"2026-01-02","current":-5.616652,"twenty":-10.432657,"median":-5.250562,"eighty":-1.988482,"marketCap":333556100},{"date":"2026-01-09","current":-5.640545,"twenty":-10.418119,"median":-5.238277,"eighty":-1.992636,"marketCap":334975047},{"date":"2026-01-16","current":-7.282885,"twenty":-10.370143,"median":-5.311221,"eighty":-1.993674,"marketCap":432508676},{"date":"2026-01-23","current":-7.76882,"twenty":-10.358512,"median":-5.340862,"eighty":-1.996789,"marketCap":461366940},{"date":"2026-01-30","current":-8.980584,"twenty":-10.345428,"median":-5.356212,"eighty":-2.000423,"marketCap":533329955},{"date":"2026-02-06","current":-8.906771,"twenty":-10.297451,"median":-5.376869,"eighty":-2.009249,"marketCap":528946421},{"date":"2026-02-13","current":-9.152815,"twenty":-10.253836,"median":-5.386426,"eighty":-2.014441,"marketCap":543558201},{"date":"2026-02-20","current":-9.841736,"twenty":-10.233483,"median":-5.400438,"eighty":-2.020671,"marketCap":584471184},{"date":"2026-02-27","current":-9.706412,"twenty":-10.211675,"median":-5.415031,"eighty":-2.032093,"marketCap":576434705},{"date":"2026-03-06","current":-8.494648,"twenty":-10.131715,"median":-5.429659,"eighty":-2.035208,"marketCap":504471690},{"date":"2026-03-13","current":-8.627788,"twenty":-10.022678,"median":-5.439635,"eighty":-2.037285,"marketCap":517477458},{"date":"2026-03-20","current":-7.538421,"twenty":-10.003778,"median":-5.449385,"eighty":-2.042477,"marketCap":452139395},{"date":"2026-03-27","current":-8.497064,"twenty":-9.968886,"median":-5.459248,"eighty":-2.051822,"marketCap":509636891},{"date":"2026-04-02","current":-8.372565,"twenty":-9.928179,"median":-5.466715,"eighty":-2.065321,"marketCap":502169684},{"date":"2026-04-10","current":-7.986617,"twenty":-9.906238,"median":-5.479061,"eighty":-2.081935,"marketCap":479021341},{"date":"2026-04-17","current":-8.27919,"twenty":-9.836054,"median":-5.512918,"eighty":-2.084012,"marketCap":496569278},{"date":"2026-04-24","current":-7.731394,"twenty":-9.810397,"median":-5.553616,"eighty":-2.100626,"marketCap":463713567},{"date":"2026-05-01","current":-7.980392,"twenty":-9.782709,"median":-5.593479,"eighty":-2.134892,"marketCap":478647981},{"date":"2026-05-08","current":-9.346147,"twenty":-9.716345,"median":-5.597332,"eighty":-2.142161,"marketCap":546226206},{"date":"2026-05-15","current":-9.090076,"twenty":-9.706412,"median":-5.616855,"eighty":-2.169158,"marketCap":531260417},{"date":"2026-05-22","current":-9.192428,"twenty":-9.705988,"median":-5.636308,"eighty":-2.233537,"marketCap":537242237},{"date":"2026-05-29","current":-8.51435,"twenty":-9.70429,"median":-5.640545,"eighty":-2.258458,"marketCap":497612677},{"date":"2026-06-05","current":-7.893845,"twenty":-9.687959,"median":-5.659308,"eighty":-2.268842,"marketCap":461347892},{"date":"2026-06-12","current":-7.586791,"twenty":-9.667944,"median":-5.675619,"eighty":-2.28961,"marketCap":443402431},{"date":"2026-06-18","current":-7.7787,"twenty":-9.662129,"median":-5.714931,"eighty":-2.297916,"marketCap":454618344},{"date":"2026-06-26","current":-8.546335,"twenty":-9.628373,"median":-5.735345,"eighty":-2.299993,"marketCap":499481996},{"date":"2026-07-02","current":-9.748963,"twenty":-9.663583,"median":-5.762064,"eighty":-2.315568,"marketCap":569768385},{"date":"2026-07-10","current":-9.883299,"twenty":-9.694491,"median":-5.794595,"eighty":-2.329935,"marketCap":577619524},{"date":"2026-07-17","current":-8.962137,"twenty":-9.694491,"median":-5.82665,"eighty":-2.336264,"marketCap":523783141},{"date":"2026-07-24","current":-9.192428,"twenty":-9.67595,"median":-5.858705,"eighty":-2.342386,"marketCap":537242237},{"date":"2026-07-31","current":-10.230297,"twenty":-9.679953,"median":-5.883363,"eighty":-2.347666,"marketCap":588835437},{"date":"2026-08-07","current":-10.033086,"twenty":-9.712752,"median":-5.989392,"eighty":-2.358877,"marketCap":577484376},{"date":"2026-08-14","current":-10.000405,"twenty":-9.736909,"median":-5.997033,"eighty":-2.370666,"marketCap":575603319},{"date":"2026-08-21","current":-10.471012,"twenty":-9.774333,"median":-6.022053,"eighty":-2.376833,"marketCap":602690534}],"updateTime":1787462366530},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CTNM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646398069","title":"Contineum Stockholders Hold 2026 Virtual Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646398069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646398069?lang=en_us&edition=fundamental","pubTime":"2026-06-27 05:19","pubTimestamp":1782508760,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics, Inc. Class A ( ($CTNM) ) has provided an update. On June 26, 2026, Contineum Therapeutics, Inc. held its 2026 Annual Meetin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/contineum-stockholders-hold-2026-virtual-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/contineum-stockholders-hold-2026-virtual-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646398580","title":"Contineum Therapeutics Shareholders Elect Class II Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646398580","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646398580?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:52","pubTimestamp":1782507142,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics shareholders elect Class II directors at annual meetingContineum Therapeutics held its annual shareholder meeting on June 26, 2026.Shareholders selected three Class II directors","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL9b002g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640967052","title":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2640967052","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640967052?lang=en_us&edition=fundamental","pubTime":"2026-06-02 06:09","pubTimestamp":1780351761,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 4,170 Class A common shares on June 1, 2026.He also reported 10,110 shares held indirectly by spouse.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbLWNZl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum Therapeutics CSO Daniel S. Lorrain disposes of 4,170 common shares for $54,866.19","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640643089","title":"Contineum Therapeutics to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640643089","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640643089?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:05","pubTimestamp":1780344334,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics will present at the 2026 Goldman Sachs Global Healthcare Conference on June 9 at 1:20 p.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL6lyJ90:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134879.HKD","LU2750360997.AUD","BK4588","LU0096364046.USD","BK4533","LU2237443895.HKD","LU2471134952.CNY","LU1868836914.USD","IE0004086264.USD","LU0868494708.USD","LU1894683264.USD","LU0061475181.USD","IE00B19Z3581.USD","LU1894683348.USD","LU1868836757.USD","LU2237438978.USD","BK4552","BK4516","LU2750360641.GBP","LU2471134523.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0048573561.USD","LU2237443978.SGD","LU1868837300.USD","LU1791807156.HKD","LU0106831901.USD","BK4550","LU0251131958.USD","BK4007","LU2471134796.USD","IE00BFXG1179.USD","BK4127","LU0345770993.USD","LU2237443622.USD","CTNM","LU0742534661.SGD","LU0345770308.USD","LU2237443382.USD","LU0868494617.USD","LU0251142724.SGD","LU0942090050.USD","LU1868837136.USD","LU1868836591.USD","LU2237443465.HKD","LU2237443549.SGD","IE0034235188.USD","BK4585","LU1804176565.USD","GSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037617","title":"Contineum Therapeutics grants 51,000-share inducement stock option to new employee","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037617?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:05","pubTimestamp":1778875523,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics granted non-qualified stock option for 51,000 shares of Class A common stock to one new non-executive employee on May 14, 2026.Exercise price set at closing price of Class A common stock on grant date.Vesting spans four years, with 25% vesting on one-year anniversary of vesting commencement date, remaining portion vesting monthly over next 36 months, subject to continued service.Option carries 10-year term under 2026 Employment Inducement Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL2Nnhz6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744984","title":"Contineum Therapeutics Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744984?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:56","pubTimestamp":1778777760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 12:56 ET (16:56 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635744119","title":"Contineum price target raised to $16 from $14 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635744119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635744119?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:50","pubTimestamp":1778777447,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Contineum (CTNM) to $16 from $14 and keeps an Equal Weight rating on the shares. Published first o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/contineum-price-target-raised-to-16-from-14-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/contineum-price-target-raised-to-16-from-14-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0528227936.USD","LU1989772923.USD","LU2089283258.USD","LU2133065610.SGD","BK4127","CTNM","BK4585","LU0557290698.USD","LU2357305700.SGD","BK4504","LU1989772840.SGD","LU2264538146.SGD","LU0106831901.USD","LU1791710582.SGD","LU2023251221.USD","LU1732800096.USD","LU0234570918.USD","BK4516","LU0098860793.USD","LU1720051017.SGD","LU0225283273.USD","LU1988902786.USD","LU2111349929.HKD","BK4007","BK4588","LU1074936037.SGD","LU0267386448.USD","LU1732799900.SGD","LU0795875169.SGD","LU1363072403.SGD","LU1791710400.SGD","LU0882574139.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU1064131342.USD","LU1720051108.HKD","LU2271345857.HKD","LU0158827948.USD","LU1244550577.SGD","LU2028103732.USD","LU0971096721.USD","BK4581","LU1548497426.USD","LU0320765646.SGD","IE00BKVL7J92.USD","LU0912757837.SGD","LU0158827781.USD","LU0006306889.USD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783716","title":"Morgan Stanley Raises Price Target on Contineum Therapeutics to $16 From $14, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783716","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783716?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:50","pubTimestamp":1778755853,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics (CTNM) has an average rating of buy and mean price target of $22.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247524","title":"Contineum Therapeutics to present at RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247524?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616333,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics scheduled to present at 2026 RBC Capital Markets Global Healthcare Conference on May 19, 2026.Management fireside chat set for 3:35 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL40yFrB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634463232","title":"Contineum presents PIPE-791 pulmonary fibrosis data at ATS 2026 conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2634463232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634463232?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:06","pubTimestamp":1778529994,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics flagged two upcoming scientific poster presentations on lead investigational candidate PIPE-791 at ATS 2026 in Orlando, scheduled for May 15-20, 2026; results will be presented in the future.One poster is set to compare PIPE-791 with a rival LPA1 antagonist, focusing on differences in lung exposure and vascular effects, positioning the program against a key competitor in pulmonary fibrosis research.A second poster is slated to show preclinical evidence that blocking LPA1 with PIPE-791 can reduce cell death in lab-based lung epithelial models, supporting the drug’s proposed protective effect in fibrotic disease biology.Both posters are scheduled for May 18, 2026, during a pulmonary fibrosis session, keeping near-term investor focus on translational data rather than clinical readouts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLc3WXC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634332475","title":"Stifel Nicolaus Remains a Buy on Contineum Therapeutics, Inc. Class A (CTNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634332475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634332475?lang=en_us&edition=fundamental","pubTime":"2026-05-11 10:39","pubTimestamp":1778467161,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Contineum Therapeutics, Inc. Class A on May 8 and set a price target of $28.00. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-contineum-therapeutics-inc-class-a-ctnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-contineum-therapeutics-inc-class-a-ctnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","SF","BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924402","title":"Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924402","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924402?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:48","pubTimestamp":1778014131,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.51) by 23.53 percent. This is a 37.1 percent increase over losses of $(0.62) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52306237/contineum-therapeutics-q1-eps-0-39-beats-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Contineum Therapeutics Q1 EPS $(0.39) Beats $(0.51) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633929741","title":"Contineum Q1 FY26 net loss narrows 9.6% to $14.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929741?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:19","pubTimestamp":1778012372,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics reported a net loss of USD 14.5 million, narrowing from USD 16 million, or USD 0.39 per share versus USD 0.62 per share.Research and development expense fell 15% to USD 11.6 million, while general and administrative costs rose 20% to USD 5.3 million.Cash, cash equivalents and marketable securities totaled USD 246.3 million, with cash runway projected through mid-2029.Positive topline data were reported from an exploratory Phase 1b chronic pain trial of PIPE-791, while dosing began in the PROPEL-IPF global Phase 2 study in first quarter 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL3XsbwJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628757","title":"Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628757","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628757?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:43","pubTimestamp":1777671806,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 4,170 shares of Class A common stock on May 1, 2026.Sales were reported at weighted average prices of $13.06 and $13.84.Lorrain reported 143,542 shares owned directly following transactions.Filing also showed 6,842 shares held indirectly by spouse.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDLbLqCyc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632642087","title":"Contineum Therapeutics grants 102,000 inducement stock options to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2632642087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632642087?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:05","pubTimestamp":1777665917,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics granted inducement equity awards to two new non-executive employees under its 2026 Employment Inducement Equity Incentive Plan.Each hire received a non-qualified stock option covering 51,000 shares of Class A common stock.Grants were dated April 28, 2026, and April 30, 2026.Options carry an exercise price equal to closing share price on each grant date.Vesting runs over four years, starting with 25% after one year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL7S29LN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632669810","title":"Contineum Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632669810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632669810?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:17","pubTimestamp":1777580258,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics will hold 2026 annual stockholders meeting virtually on June 26, 2026.Vote scheduled on election of three Class II directors to serve until 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL5Zn6zL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632866629","title":"Contineum reports positive Phase 1b data for PIPE-791 in chronic pain trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2632866629","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632866629?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:17","pubTimestamp":1777580235,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics reported positive topline results from exploratory Phase 1b trial of PIPE-791 in chronic osteoarthritis pain or chronic low back pain.Results have been presented as topline data, with trial meeting primary endpoint on safety and tolerability.Exploratory efficacy readouts showed encouraging trends in pain and functional patient-reported outcomes, generally favoring PIPE-791 over placebo.PIPE-791 was tested as once-daily 10 mg oral dose in 43 patients across two 4-week crossover treatment periods.Data supported further evaluation of PIPE-791 in chronic pain, with Contineum weighing next clinical development steps.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL8cCGkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632982665","title":"Contineum Therapeutics Inc - Pipe-791 Phase 1B Trial Achieves Primary Endpoint for Safety and Tolerability","url":"https://stock-news.laohu8.com/highlight/detail?id=2632982665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632982665?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:05","pubTimestamp":1777579502,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA2RLKHT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632366593","title":"Contineum Therapeutics Reports Positive Topline Data From Its Exploratory Pipe-791 Phase 1B Trial in Chronic Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2632366593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632366593?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:05","pubTimestamp":1777579502,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA2RLKHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632106665","title":"Contineum Therapeutics Inc - No Serious Adverse Events Reported in Pipe-791 Phase 1B Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2632106665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632106665?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:05","pubTimestamp":1777579502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA2RLKHT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTNM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":61,"code":"91000000","status":"200"}]}}